Description
Dasatinib tablets are used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) by inhibiting BCR-ABL protein, which drives cancer cell growth. It helps reduce cancer cell proliferation, improve survival, and manage leukemia progression.